{"id":"W2581368499","doi":"10.1016/j.tcm.2017.01.009","title":"The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors","year":2017,"lang":"en","type":"review","venue":"Trends in Cardiovascular Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; University Health Network; University of Toronto; Women's College Hospital; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Alogliptin; Medicine; Empagliflozin; Semaglutide; Saxagliptin; Sitagliptin; Heart failure; Lixisenatide; Type 2 diabetes; Dulaglutide; Liraglutide; Internal medicine; Dapagliflozin; Dipeptidyl peptidase-4; Population; Pharmacology; Diabetes mellitus; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003108741,0.0009050826,0.003742188,0.001122689,0.0001744023,0.001067474,0.00131532,0.001431329,0.00476923],"category_scores_gemma":[0.00467572,0.0003008153,0.002643551,0.001469049,0.0003090026,0.0009145849,0.0005422803,0.002180824,0.0005374541],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005694097,"about_ca_system_score_gemma":0.001345983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001027146,"about_ca_topic_score_gemma":0.003327853,"domain_scores_codex":[0.999019,0.000295857,0.0002431653,0.0001299281,0.0002500842,0.0000619215],"domain_scores_gemma":[0.9967421,0.002345311,0.0005097238,0.00004561046,0.0002734016,0.00008392544],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003107902,0.0001192008,0.000494399,0.1487897,0.004400486,0.0001451458,0.0000646183,0.0003309131,0.001063521,0.001546409,0.02407837,0.8158594],"study_design_scores_gemma":[0.009381811,0.003425389,0.01124454,0.1578917,0.04260577,0.001820084,0.00036299,0.0004924757,0.00172147,0.005767357,0.7651471,0.0001393802],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002890673,0.9987948,0.00004725194,0.0002814454,0.0001249329,0.00001338001,0.00004876466,0.00000334528,0.0003970823],"genre_scores_gemma":[0.00363644,0.9944426,0.0002160719,0.001117656,0.0002049681,0.00002437823,0.0001069381,0.000002539826,0.0002483877],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00476923,"threshold_uncertainty_score":0.01644081,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1154507040491829,"score_gpt":0.3786707929696252,"score_spread":0.2632200889204423,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}